GO:0010878 cholesterol storage: Cellular Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010878 cholesterol storage describes the accumulation and maintenance of cholesterol (cholest-5-en-3 beta-ol) in cells or tissues.
• Cholesterol storage is a regulated biological process, not merely passive deposition; it involves esterification by SOAT enzymes and packaging into lipid droplets.
• Defective cholesterol storage underlies Niemann-Pick type C disease, where unesterified cholesterol accumulates in late endosomes/lysosomes.
• In cancer, cholesterol storage can be modulated by signaling pathways such as FGFR and is linked to tumor cell invasion.
• Pharmacological inhibition of HSP90 reduces cholesterol storage in Niemann-Pick type C1 mutant fibroblasts, highlighting therapeutic avenues.
• Studying cholesterol storage requires integrated methods including lipidomics, imaging, and CRISPR-based gene editing to dissect causal genes.
Description
Cholesterol is an essential sterol in vertebrate cells, serving as a structural component of membranes and a precursor for bile acids, steroid hormones, and vitamin D. The biological process termed cholesterol storage (GO:0010878) refers to the accumulation and maintenance of cholesterol within cells or tissues. This process is distinct from cholesterol synthesis and transport, although it is tightly interconnected with them. Dysregulation of cholesterol storage is a hallmark of several human disorders, most notably Niemann-Pick type C disease, where mutations in NPC1 or NPC2 lead to massive accumulation of unesterified cholesterol in endolysosomal compartments. Understanding the molecular players and regulatory mechanisms of cholesterol storage is therefore critical for both basic cell biology and therapeutic development. Recent studies have shown that cholesterol storage is not a passive process but is actively regulated by enzymes such as SOAT1 and signaling pathways including FGFR. Moreover, lipid droplets, the primary organelles for cholesterol ester storage, are dynamic structures that can be mobilized through lipolysis, linking storage to signaling and foam cell remodeling. This article provides a comprehensive overview of GO:0010878, integrating authoritative QuickGO data with real PubMed literature to guide researchers in experimental design and interpretation.
cholesterol storage At A Glance
| GO ID | GO:0010878 |
|---|---|
| GO term | cholesterol storage |
| Ontology | biological_process |
| Synonym | cholesterol sequestration; sequestration of cholesterol |
| Major function | Accumulation and maintenance of cholesterol in cells or tissues |
| Related cellular components | Lipid droplets, late endosomes/lysosomes, plasma membrane |
| Key enzymes | SOAT1, SOAT2, NPC1, NPC2, HSP90 |
| Associated diseases | Niemann-Pick type C disease, atherosclerosis, cancer |
| Research methods | Lipidomics, fluorescence microscopy, CRISPR screens, biochemical assays |
What Is GO:0010878?
According to the Gene Ontology, cholesterol storage (GO:0010878) is defined as the accumulation and maintenance in cells or tissues of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. This process encompasses the sequestration of cholesterol in specific cellular compartments, often in esterified form within lipid droplets, and its retention over time. It is a biological process that can be distinguished from cholesterol biosynthesis, transport, or efflux, although it is functionally linked to these pathways.
Why Is cholesterol storage Important in Cell Biology?
Cholesterol storage is fundamental to cellular physiology because it regulates the availability of free cholesterol for membrane synthesis, signaling, and steroidogenesis. When this process is perturbed, cells can accumulate toxic levels of unesterified cholesterol, leading to lysosomal dysfunction, inflammation, and cell death, as seen in Niemann-Pick type C disease. Moreover, cholesterol storage in macrophages contributes to foam cell formation and atherosclerosis. In cancer, altered cholesterol storage supports rapid proliferation and invasion, and targeting this process may offer therapeutic benefits. Thus, understanding the mechanisms of cholesterol storage is essential for developing interventions against a range of metabolic, neurodegenerative, and oncological diseases.
• Maintains cellular cholesterol homeostasis by storing excess cholesterol as cholesteryl esters in lipid droplets.
• Prevents lipotoxicity from free cholesterol accumulation in membranes and organelles.
• Dysregulation causes Niemann-Pick type C disease, a fatal neurodegenerative disorder.
• Contributes to foam cell formation and atherosclerosis progression.
• Supports cancer cell proliferation and invasion through SOAT1-dependent mechanisms.
• Serves as a target for pharmacological intervention, e.g., HSP90 inhibitors reduce storage in NPC1 mutant cells.
• Involved in dietary cholesterol oxidation product metabolism and health implications.
• Provides a model system to study lipid droplet biology and organelle interactions.
• Links to signaling pathways such as FGFR that modulate storage in a SOAT1-dependent manner.
• Enables research on inborn errors of sphingolipid and cholesterol metabolism.
What Happens During cholesterol storage?
Cholesterol Uptake and Synthesis
In simple terms: Cells acquire cholesterol either by making it or by taking it up from outside.
Cholesterol can be synthesized endogenously via the mevalonate pathway or taken up from lipoproteins through receptor-mediated endocytosis. In the context of storage, excess cholesterol from either source can be directed toward storage compartments. The balance between synthesis, uptake, and efflux determines the amount of cholesterol available for storage.
Esterification by SOAT Enzymes
In simple terms: Enzymes called SOAT convert free cholesterol into cholesteryl esters, which can be stored.
Sterol O-acyltransferase 1 (SOAT1) and SOAT2 catalyze the esterification of cholesterol with fatty acids to form cholesteryl esters. This reaction is critical for cholesterol storage because esterified cholesterol is more hydrophobic and can be packaged into lipid droplets. SOAT1 is ubiquitously expressed and its activity is often upregulated in cells with high cholesterol storage, such as foam cells and cancer cells.
Packaging into Lipid Droplets
In simple terms: Cholesteryl esters are packed into lipid droplets, which are storage organelles.
Cholesteryl esters are sequestered within the hydrophobic core of lipid droplets, which are ubiquitous organelles consisting of a neutral lipid core surrounded by a phospholipid monolayer and associated proteins. Lipid droplets serve as dynamic storage depots that can be mobilized by lipases when cholesterol is needed. The formation and growth of lipid droplets are regulated by multiple proteins, including perilipins and DGAT enzymes.
Lysosomal Cholesterol Export and Storage
In simple terms: Cholesterol from degraded lipoproteins must exit the lysosome; if this fails, it accumulates.
Cholesterol derived from the endocytic pathway is delivered to late endosomes/lysosomes, where NPC1 and NPC2 proteins mediate its export to other cellular membranes. Mutations in NPC1 or NPC2 cause Niemann-Pick type C disease, characterized by massive accumulation of unesterified cholesterol in lysosomes, a form of cholesterol storage. This storage leads to secondary defects in lipid trafficking and cellular dysfunction.
Mobilization and Turnover
In simple terms: Stored cholesterol can be released when cells need it.
Cholesteryl esters in lipid droplets can be hydrolyzed by neutral cholesteryl ester hydrolases, releasing free cholesterol for membrane synthesis or signaling. This mobilization is particularly important in macrophage foam cells, where lipolysis can reverse cholesterol storage and promote cholesterol efflux. The balance between esterification and hydrolysis determines the net storage of cholesterol.
Key Genes Involved in GO:0010878 cholesterol storage
The following genes and proteins are central to the regulation and execution of cholesterol storage, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOAT1 | Esterifies cholesterol to form cholesteryl esters for storage | Target for reducing cholesterol storage in cancer and atherosclerosis |
| SOAT2 | Esterifies cholesterol in liver and intestine | Involved in lipoprotein assembly and dietary cholesterol absorption |
| NPC1 | Mediates lysosomal export of cholesterol | Mutations cause Niemann-Pick type C disease with cholesterol storage |
| NPC2 | Binds cholesterol in lysosome for transfer to NPC1 | Mutations cause Niemann-Pick type C disease |
| HSP90 | Chaperone that stabilizes NPC1 and other proteins | Inhibition reduces cholesterol storage in NPC1 mutant fibroblasts |
| ABCA1 | Mediates cholesterol efflux to apoA-I | Counteracts storage by promoting efflux |
| ABCG1 | Mediates cholesterol efflux to HDL | Regulates cellular cholesterol balance |
| SCAP | Senses cholesterol and regulates SREBP processing | Controls cholesterol synthesis and uptake, indirectly affecting storage |
| INSIG | Retains SCAP in ER when cholesterol is high | Negative regulator of cholesterol synthesis |
| SREBP2 | Transcription factor activating cholesterol synthesis genes | Influences cholesterol availability for storage |
| LXR | Nuclear receptor promoting cholesterol efflux and reverse transport | Reduces storage by increasing ABCA1/ABCG1 |
| DGAT1 | Synthesizes triglycerides and cholesteryl esters for lipid droplets | Affects lipid droplet formation and cholesterol storage |
| DGAT2 | Synthesizes triglycerides in lipid droplets | Contributes to lipid droplet biogenesis |
| PLIN1 | Perilipin coats lipid droplets and regulates lipolysis | Controls mobilization of stored cholesterol |
| PLIN2 | Perilipin family member stabilizing lipid droplets | Marker of lipid droplet accumulation |
| FGFR1 | Receptor tyrosine kinase signaling to SOAT1 | Modulates cholesterol storage in mammary tumor cells |
| FGFR2 | Receptor tyrosine kinase signaling | Potential role in cholesterol storage regulation |
| CYP27A1 | Converts cholesterol to bile acids | Affects cholesterol catabolism and storage |
How Is cholesterol storage Regulated?
Cholesterol storage is regulated at multiple levels. The SREBP-SCAP-INSIG pathway senses endoplasmic reticulum cholesterol levels and controls the expression of genes involved in cholesterol synthesis and uptake, thereby influencing the amount of cholesterol available for storage. The LXR pathway promotes cholesterol efflux and reduces storage by upregulating ABCA1 and ABCG1. SOAT1 activity is post-transcriptionally regulated and can be modulated by signaling pathways such as FGFR, which promotes cholesterol storage in a SOAT1-dependent manner in mammary tumor cells. Additionally, HSP90 inhibition reduces cholesterol storage in Niemann-Pick type C1 mutant fibroblasts, suggesting a role for chaperone-mediated regulation of NPC1 stability. Lipid droplet-associated proteins such as perilipins regulate the hydrolysis of stored cholesteryl esters, providing another layer of control.
cholesterol storage and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPC1 | Niemann-Pick type C disease | NPC1 knockout HeLa or fibroblast cells; patient-derived fibroblasts |
| NPC2 | Niemann-Pick type C disease | NPC2 knockout cells; overexpression of mutant NPC2 |
| SOAT1 | Cancer invasion, atherosclerosis | SOAT1 knockout or overexpression in cancer cell lines |
| HSP90 | Niemann-Pick type C disease (modifier) | HSP90 inhibitor treatment in NPC1 mutant fibroblasts |
| FGFR1 | Breast cancer invasion | FGFR1 knockdown or overexpression in mammary tumor cells |
Niemann-Pick Type C Disease
Niemann-Pick type C (NPC) disease is an autosomal recessive lysosomal storage disorder caused by mutations in NPC1 or NPC2, leading to massive accumulation of unesterified cholesterol in late endosomes/lysosomes. This cholesterol storage triggers neurodegeneration, hepatosplenomegaly, and premature death. Studies in NPC1 mutant fibroblasts have shown that HSP90 inhibitors can reduce cholesterol storage, offering a potential therapeutic strategy. The unique case of NPC has provided critical insights into intracellular cholesterol trafficking and storage.
Atherosclerosis and Foam Cell Formation
In atherosclerosis, macrophages take up modified lipoproteins and accumulate cholesteryl esters, becoming foam cells. This cholesterol storage is a hallmark of early atherosclerotic lesions. Lipid droplet lipolysis and remodeling influence foam cell phenotype and reverse cholesterol transport. Dietary cholesterol oxidation products may also impact cholesterol storage and health.
Cancer
Cancer cells often exhibit altered cholesterol metabolism, including increased cholesterol storage. In mammary tumor cells, FGFR signaling modulates cholesterol storage in a SOAT1-dependent manner to promote invasion. Targeting SOAT1 or cholesterol storage pathways may therefore inhibit tumor progression.
From cholesterol storage-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NPC1 cause cholesterol storage? | NPC1 knockout cell line (e.g., HeLa) |
| Can SOAT1 inhibition reduce cholesterol storage? | SOAT1 knockout or pharmacological inhibition in foam cells |
| Does mutant NPC2 fail to export cholesterol? | Point mutation knock-in of NPC2 in cells |
| How does HSP90 inhibition affect cholesterol storage? | HSP90 inhibitor treatment in NPC1 mutant fibroblasts |
| Does FGFR signaling regulate cholesterol storage? | FGFR1 knockout or overexpression in mammary tumor cells |
| Can cholesterol storage be visualized in live cells? | Knock-in of fluorescently tagged NPC1 or lipid droplet markers |
How to Study the cholesterol storage Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Filipin staining | Unesterified cholesterol accumulation | Diagnosis of NPC disease, drug screening |
| Lipidomics (LC-MS) | Free cholesterol and cholesteryl ester levels | Quantifying storage in cells and tissues |
| BODIPY 493/503 | Neutral lipid droplets | Visualizing lipid droplet accumulation |
| CRISPR knockout screen | Genes regulating cholesterol storage | Identifying SOAT1 and other modulators |
| SOAT activity assay | Cholesterol esterification rate | Evaluating enzyme function and inhibition |
| Western blot | Protein levels of NPC1, SOAT1, etc. | Validating knockout or overexpression |
| RNA-seq | Transcriptional changes in storage pathways | Identifying SREBP/LXR target genes |
| Immunofluorescence | Subcellular localization of cholesterol | Tracking lysosomal cholesterol export |
Lipidomics and Cholesterol Quantification
Mass spectrometry-based lipidomics allows precise quantification of free cholesterol and cholesteryl esters in cells and tissues. This method is essential for confirming cholesterol storage phenotypes and for screening compounds that modulate storage.
Fluorescence Microscopy and Imaging
Filipin staining is a classic method to visualize unesterified cholesterol accumulation in cells, particularly in lysosomes of NPC mutant cells. Lipid droplets can be visualized with neutral lipid dyes such as BODIPY 493/503 or by tagging lipid droplet proteins.
CRISPR Screens and Gene Editing
Genome-wide CRISPR knockout screens can identify genes that regulate cholesterol storage. For example, SOAT1 was identified as a key modulator of cholesterol storage in cancer cells using CRISPR approaches. Knock-in of disease mutations (e.g., NPC1) enables modeling of cholesterol storage disorders.
Biochemical Assays for Esterification
SOAT activity can be measured using radiolabeled cholesterol or fluorescent substrates, allowing assessment of cholesterol esterification rates in cell lysates. This is useful for dissecting the enzymatic basis of storage.
How CRISPR Can Be Used to Study GO:0010878 cholesterol storage
Knockout
CRISPR knockout of genes such as NPC1, NPC2, or SOAT1 is used to model cholesterol storage disorders and to dissect their roles in the process. For example, NPC1 knockout cells accumulate unesterified cholesterol in lysosomes, mimicking Niemann-Pick type C disease. SOAT1 knockout reduces cholesteryl ester storage and can inhibit cancer cell invasion.
Point Mutation
Point mutations identified in patients with cholesterol storage disorders (e.g., NPC1 or NPC2 mutations) can be introduced into cell lines using CRISPR knock-in to study their functional impact on cholesterol trafficking and storage. This approach provides insights into genotype-phenotype relationships.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci of NPC1 or lipid droplet proteins allows real-time visualization of cholesterol storage dynamics in live cells. Additionally, knock-in of disease-relevant mutations enables precise modeling of storage defects.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can be used to increase levels of genes such as SOAT1 or NPC1 to study their effects on cholesterol storage. Overexpression of SOAT1 enhances cholesteryl ester storage and lipid droplet formation.
How EDITGENE Supports cholesterol storage Research
Researchers studying cholesterol storage-related genes often need to determine whether a candidate gene is causally involved in the accumulation and maintenance of cholesterol. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional interrogation of cholesterol storage pathways.
Contact EDITGENE today to design your custom CRISPR model for cholesterol storage research.
Frequently Asked Questions About cholesterol storage
What is cholesterol storage (GO:0010878)?
Cholesterol storage is the biological process of accumulation and maintenance of cholesterol in cells or tissues, as defined by the Gene Ontology.
What genes are involved in cholesterol storage?
Key genes include NPC1, NPC2, SOAT1, SOAT2, HSP90, ABCA1, ABCG1, and FGFR1, among others.
What diseases are associated with defective cholesterol storage?
Niemann-Pick type C disease, atherosclerosis, and cancer are major diseases linked to altered cholesterol storage.
How is cholesterol storage measured in the lab?
Common methods include Filipin staining, lipidomics, BODIPY staining of lipid droplets, and SOAT activity assays.
What is the role of SOAT1 in cholesterol storage?
SOAT1 esterifies cholesterol to form cholesteryl esters, which are stored in lipid droplets; its inhibition reduces storage.
Can CRISPR be used to study cholesterol storage?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in cholesterol storage.
What is Niemann-Pick type C disease?
It is a lysosomal storage disorder caused by mutations in NPC1 or NPC2, leading to massive cholesterol accumulation in lysosomes.
How does HSP90 affect cholesterol storage?
HSP90 inhibition reduces cholesterol storage in NPC1 mutant fibroblasts, likely by destabilizing NPC1.
What are lipid droplets and how do they relate to cholesterol storage?
Lipid droplets are organelles that store cholesteryl esters and triglycerides; they are central to cholesterol storage.
What model systems are used to study cholesterol storage?
Cell lines (e.g., HeLa, fibroblasts), primary cells, and animal models with CRISPR edits are commonly used.
Conclusion
Cholesterol storage (GO:0010878) is a vital biological process that maintains cellular cholesterol homeostasis and prevents lipotoxicity. Its dysregulation is central to Niemann-Pick type C disease, atherosclerosis, and cancer, making it a key area of biomedical research. Advances in CRISPR gene editing and lipidomics have accelerated the discovery of molecular players such as SOAT1, NPC1, and HSP90, and have opened new therapeutic avenues. Continued research into the mechanisms and regulation of cholesterol storage will be essential for developing targeted interventions against related diseases.
References
- 1. Luo J et al.. 2020. Mechanisms and regulation of cholesterol homeostasis.. Nat Rev Mol Cell Biol 21(4):225-245 PMID: 31848472
- 2. Liu Y et al.. 2022. Dietary cholesterol oxidation products: Perspectives linking food processing and storage with health implications.. Compr Rev Food Sci Food Saf 21(1):738-779 PMID: 34953101
- 3. Pfrieger FW. 2023. The Niemann-Pick type diseases - A synopsis of inborn errors in sphingolipid and cholesterol metabolism.. Prog Lipid Res 90:101225 PMID: 37003582
- 4. Pipalia NH et al.. 2021. HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts.. J Lipid Res 62:100114 PMID: 34481829
- 5. Paul A. 2026. From Storage to Signaling: Lipid Droplet Lipolysis in Cholesterol Mobilization and Foam Cell Remodeling.. Curr Atheroscler Rep 28(1) PMID: 41995911
- 6. Klein AD et al.. 2014. The unique case of the Niemann-Pick type C cholesterol storage disorder.. Pediatr Endocrinol Rev 12 Suppl 1:166-75 PMID: 25345099
- 8. Tuokkola JE et al.. 2025. Fibroblast growth factor receptor signaling modulates cholesterol storage in a SOAT1-dependent manner to promote mammary tumor cell invasion.. Breast Cancer Res 27(1):132 PMID: 40665359
